| 产品详情 |
| Edit |   |
|---|
| Product Name | 4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid |
|---|
| Description | 4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout. Molecular Formula: C21H20N4O5S Molecular Weight: 440.47 |
|---|
| Size | 1mg, 2.5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 429907 |
|---|
| Price | |
|---|
| Order / More Info | 4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|